Representatives from the University of Kentucky, the Woodbury Corporation and state and local officials celebrated the official opening of The CoRE — Collaboration. Research. Entrepreneurship facility at UK’s Coldstream Research Campus.
As part of the partnership, Summit will manufacture a multidose nasal spray presentation of AdCOVID, Altimmune’s intranasal COVID-19 vaccine candidate. AdCOVID is currently being evaluated in a phase 1 clinical trial of healthy adult volunteers between the ages of 18 and 55.
